Journalist Liz Scherer writes to inform us that:
“The International Menopause Society (IMS) joined forces this year with Novo Nordisk FemCare Ag (marketers of Activella®) to ‘end silent suffering’ and promote recommendations for the management of vaginal atrophy during the menopause. A key problem, they say, is that results of a phone survey show that women are not discussing vaginal atrophy with their practitioners, who in turn, are not openly asking questions about vaginal health.
… aren’t we being a bit alarmist about the ‘silent suffering’ of women with this chronic condition?
Mind you, I am not mocking or doubting the horrible impact that vaginal atrophy can have on a woman’s life. In fact, aging and its accompanying aches and pains aren’t fun. Neither are hot flashes, night sweats, mood swings or vaginal pain.
I hardly believe that we’re on the verge of an atrophy epidemic or that we need to dramatize the “silent suffering” countless women across the globe.”
Thanks, Liz. We probably wouldn’t have caught this one. And your observations are important. Read her entire thoughtful column, not just these excerpts.